Unknown

Dataset Information

0

STOMPing Out Hormone-Sensitive Metastases With Local Therapies in Prostate Cancer.

ABSTRACT:

SUBMITTER: Phillips RM 

PROVIDER: S-EPMC9250283 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Systemic therapies for metastatic hormone-sensitive prostate cancer: network meta-analysis.
| S-EPMC9291853 | biostudies-literature
Unknown Radium-223 for primary bone metastases in patients with hormone-sensitive prostate cancer after radical prostatectomy.
| S-EPMC5546468 | biostudies-literature
Unknown Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer.
| S-EPMC4562797 | biostudies-literature
Unknown Lutetium-177-PSMA-I&T as metastases directed therapy in oligometastatic hormone sensitive prostate cancer, a randomized controlled trial.
| S-EPMC7490874 | biostudies-literature
Unknown Oligometastatic and Oligoprogression Disease and Local Therapies in Prostate Cancer.
| S-EPMC7101059 | biostudies-literature
Unknown Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer: A Comprehensive Review.
| S-EPMC5990677 | biostudies-literature
Unknown Metastatic hormone-sensitive prostate cancer: How should it be treated?
| S-EPMC7918528 | biostudies-literature
Unknown WHO SHOULD RECEIVE RADIOTHERAPY IN METASTATIC HORMONE-SENSITIVE PROSTATE CANCER?
| S-EPMC8693553 | biostudies-literature
Unknown Recent Advances in the Management of Hormone-Sensitive Oligometastatic Prostate Cancer.
| S-EPMC8747627 | biostudies-literature
Unknown Docetaxel Treatment for Metastatic Hormone-sensitive Prostate Cancer in Daily Practice.
| S-EPMC8546919 | biostudies-literature